Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain
Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to...
Saved in:
Published in | Nature communications Vol. 8; no. 1; pp. 1001 - 9 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
17.10.2017
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
ISSN | 2041-1723 2041-1723 |
DOI | 10.1038/s41467-017-00952-3 |
Cover
Abstract | Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to efficiently reach neurons. Here we prepare a self-assembled supramolecular nanocarrier with a surface featuring properly configured glucose. The BBB crossing and brain accumulation of this nanocarrier are boosted by the rapid glycaemic increase after fasting and by the putative phenomenon of the highly expressed glucose transporter-1 (GLUT1) in brain capillary endothelial cells migrating from the luminal to the abluminal plasma membrane. The precisely controlled glucose density on the surface of the nanocarrier enables the regulation of its distribution within the brain, and thus is successfully optimized to increase the number of nanocarriers accumulating in neurons.
There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid glycaemic increase the accumulation of a glucosylated nanocarrier in the brain can be controlled. |
---|---|
AbstractList | There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid glycaemic increase the accumulation of a glucosylated nanocarrier in the brain can be controlled. Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to efficiently reach neurons. Here we prepare a self-assembled supramolecular nanocarrier with a surface featuring properly configured glucose. The BBB crossing and brain accumulation of this nanocarrier are boosted by the rapid glycaemic increase after fasting and by the putative phenomenon of the highly expressed glucose transporter-1 (GLUT1) in brain capillary endothelial cells migrating from the luminal to the abluminal plasma membrane. The precisely controlled glucose density on the surface of the nanocarrier enables the regulation of its distribution within the brain, and thus is successfully optimized to increase the number of nanocarriers accumulating in neurons.There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid glycaemic increase the accumulation of a glucosylated nanocarrier in the brain can be controlled. Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to efficiently reach neurons. Here we prepare a self-assembled supramolecular nanocarrier with a surface featuring properly configured glucose. The BBB crossing and brain accumulation of this nanocarrier are boosted by the rapid glycaemic increase after fasting and by the putative phenomenon of the highly expressed glucose transporter-1 (GLUT1) in brain capillary endothelial cells migrating from the luminal to the abluminal plasma membrane. The precisely controlled glucose density on the surface of the nanocarrier enables the regulation of its distribution within the brain, and thus is successfully optimized to increase the number of nanocarriers accumulating in neurons. Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to efficiently reach neurons. Here we prepare a self-assembled supramolecular nanocarrier with a surface featuring properly configured glucose. The BBB crossing and brain accumulation of this nanocarrier are boosted by the rapid glycaemic increase after fasting and by the putative phenomenon of the highly expressed glucose transporter-1 (GLUT1) in brain capillary endothelial cells migrating from the luminal to the abluminal plasma membrane. The precisely controlled glucose density on the surface of the nanocarrier enables the regulation of its distribution within the brain, and thus is successfully optimized to increase the number of nanocarriers accumulating in neurons.There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid glycaemic increase the accumulation of a glucosylated nanocarrier in the brain can be controlled.Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to efficiently reach neurons. Here we prepare a self-assembled supramolecular nanocarrier with a surface featuring properly configured glucose. The BBB crossing and brain accumulation of this nanocarrier are boosted by the rapid glycaemic increase after fasting and by the putative phenomenon of the highly expressed glucose transporter-1 (GLUT1) in brain capillary endothelial cells migrating from the luminal to the abluminal plasma membrane. The precisely controlled glucose density on the surface of the nanocarrier enables the regulation of its distribution within the brain, and thus is successfully optimized to increase the number of nanocarriers accumulating in neurons.There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid glycaemic increase the accumulation of a glucosylated nanocarrier in the brain can be controlled. Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to efficiently reach neurons. Here we prepare a self-assembled supramolecular nanocarrier with a surface featuring properly configured glucose. The BBB crossing and brain accumulation of this nanocarrier are boosted by the rapid glycaemic increase after fasting and by the putative phenomenon of the highly expressed glucose transporter-1 (GLUT1) in brain capillary endothelial cells migrating from the luminal to the abluminal plasma membrane. The precisely controlled glucose density on the surface of the nanocarrier enables the regulation of its distribution within the brain, and thus is successfully optimized to increase the number of nanocarriers accumulating in neurons. There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid glycaemic increase the accumulation of a glucosylated nanocarrier in the brain can be controlled. |
ArticleNumber | 1001 |
Author | Osada, K. Anraku, Y. Toh, K. Kataoka, K. Uchida, S. Itaka, K. Nishiyama, N. Mizusawa, H. Mizoguchi, A. Fukusato, Y. Yokota, T. Ishii, T. Nishina, K. Nitta, K. Miyata, K. Kuwahara, H. Yamasoba, T. Matsumoto, Y. |
Author_xml | – sequence: 1 givenname: Y. surname: Anraku fullname: Anraku, Y. organization: Department of Bioengineering, Graduate School of Engineering, The University of Tokyo – sequence: 2 givenname: H. surname: Kuwahara fullname: Kuwahara, H. organization: Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Center for Brain Integration Research, Tokyo Medical and Dental University (TMDU) – sequence: 3 givenname: Y. surname: Fukusato fullname: Fukusato, Y. organization: Department of Bioengineering, Graduate School of Engineering, The University of Tokyo – sequence: 4 givenname: A. surname: Mizoguchi fullname: Mizoguchi, A. organization: Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo – sequence: 5 givenname: T. surname: Ishii fullname: Ishii, T. organization: Department of Bioengineering, Graduate School of Engineering, The University of Tokyo – sequence: 6 givenname: K. surname: Nitta fullname: Nitta, K. organization: Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Center for Brain Integration Research, Tokyo Medical and Dental University (TMDU) – sequence: 7 givenname: Y. orcidid: 0000-0002-0530-1326 surname: Matsumoto fullname: Matsumoto, Y. organization: Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Department of Otorhinolaryngology and Head and Neck Surgery, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo – sequence: 8 givenname: K. surname: Toh fullname: Toh, K. organization: Innovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion – sequence: 9 givenname: K. surname: Miyata fullname: Miyata, K. organization: Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Department of Materials Engineering, Graduate School of Engineering, The University of Tokyo – sequence: 10 givenname: S. surname: Uchida fullname: Uchida, S. organization: Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo – sequence: 11 givenname: K. surname: Nishina fullname: Nishina, K. organization: Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Center for Brain Integration Research, Tokyo Medical and Dental University (TMDU) – sequence: 12 givenname: K. surname: Osada fullname: Osada, K. organization: Department of Bioengineering, Graduate School of Engineering, The University of Tokyo – sequence: 13 givenname: K. surname: Itaka fullname: Itaka, K. organization: Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo – sequence: 14 givenname: N. surname: Nishiyama fullname: Nishiyama, N. organization: Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology – sequence: 15 givenname: H. surname: Mizusawa fullname: Mizusawa, H. organization: Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Center for Brain Integration Research, Tokyo Medical and Dental University (TMDU) – sequence: 16 givenname: T. surname: Yamasoba fullname: Yamasoba, T. organization: Department of Otorhinolaryngology and Head and Neck Surgery, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo – sequence: 17 givenname: T. surname: Yokota fullname: Yokota, T. email: tak-yokota.nuro@tmd.ac.jp organization: Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Center for Brain Integration Research, Tokyo Medical and Dental University (TMDU) – sequence: 18 givenname: K. surname: Kataoka fullname: Kataoka, K. email: kataoka@bmw.t.u-tokyo.ac.jp organization: Innovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, Policy Alternatives Research Institute, The University of Tokyo |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29042554$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Ul1rFDEUDVKxtfYP-CADvvgymo-bmcmL4BathYII-hwymcw0SzapSUbYf292ppZtQQMhX-ecXO45L9GJD94g9Jrg9wSz7kMCAk1bY1ImFpzW7Bk6oxhITVrKTo72p-gipS0ugwnSAbxAp1RgoJzDGfp-5fZamZ3VlQ4-x-CqPoSUUzW5WYe0dyqbofLKB61itCZWOoaUrJ-qfGuqzWZTWZ_Dcuijsv4Vej4ql8zF_XqOfn75_OPya33z7er68tNNrXkHuebc9HxsgDQDGxthhlHgTmtgFIAIA0xBK8Soup43rR7wAJoIANEDa6nChJ2j61V3CGor76LdqbiXQVm5XIQ4SRWz1c5IPGoCbBh1Cw1oajrMDGWi74qo7oEWrY-r1t3c78ygTemEco9EH794eyun8FvyBjjrRBF4dy8Qw6_ZpCx3NmnjnPImzEmS4hCnoqFQoG-fQLdhjr60akGRhrbigHpzXNFDKX-dKwC6AhY7ohkfIATLQ0LkmhBZEiKXhEhWSN0TkrZZZXtwXln3fypbqan84ycTj8r-N-sPfODOzg |
CitedBy_id | crossref_primary_10_1002_tox_24259 crossref_primary_10_1016_j_jconrel_2023_10_019 crossref_primary_10_1248_cpb_c20_00041 crossref_primary_10_1016_j_addr_2020_06_007 crossref_primary_10_1021_acs_biomac_8b01406 crossref_primary_10_1038_s41578_024_00695_w crossref_primary_10_1002_pep2_24392 crossref_primary_10_1039_C8CS00805A crossref_primary_10_1016_j_addr_2023_115073 crossref_primary_10_2147_IJN_S457393 crossref_primary_10_1039_D3NA01125A crossref_primary_10_1080_17425247_2023_2255138 crossref_primary_10_1021_acs_bioconjchem_2c00389 crossref_primary_10_1007_s12088_024_01330_6 crossref_primary_10_1002_advs_202003937 crossref_primary_10_3389_fimmu_2023_1241791 crossref_primary_10_1016_j_cis_2023_103008 crossref_primary_10_1021_acsnano_4c05906 crossref_primary_10_1021_acs_molpharmaceut_9b00691 crossref_primary_10_1039_D0RA10392F crossref_primary_10_3390_pharmaceutics13071003 crossref_primary_10_1021_acs_biomac_0c01661 crossref_primary_10_1007_s10853_019_04079_2 crossref_primary_10_1039_D4ME00105B crossref_primary_10_1021_acs_chemrev_0c01338 crossref_primary_10_1021_acs_macromol_0c02031 crossref_primary_10_1021_acsnano_3c09715 crossref_primary_10_1016_j_lfs_2021_119129 crossref_primary_10_1021_acs_nanolett_3c00377 crossref_primary_10_1021_acs_bioconjchem_4c00555 crossref_primary_10_2745_dds_33_335 crossref_primary_10_1021_acsmacrolett_8b00812 crossref_primary_10_1002_adfm_202312595 crossref_primary_10_1126_sciadv_abm7077 crossref_primary_10_1016_j_addr_2022_114480 crossref_primary_10_1021_acs_nanolett_3c04175 crossref_primary_10_1016_j_addr_2020_10_001 crossref_primary_10_1080_17425247_2023_2245332 crossref_primary_10_1073_pnas_2002016117 crossref_primary_10_1186_s12951_023_02022_x crossref_primary_10_1039_D4MH00325J crossref_primary_10_3390_molecules28237750 crossref_primary_10_1080_1061186X_2021_1904250 crossref_primary_10_70401_bmeh_2024_124 crossref_primary_10_1007_s44258_023_00004_0 crossref_primary_10_1093_jmicro_dfac005 crossref_primary_10_1016_j_biomaterials_2022_121640 crossref_primary_10_3389_fnins_2023_1137096 crossref_primary_10_1002_adhm_202202688 crossref_primary_10_1016_j_mtchem_2022_101104 crossref_primary_10_1039_C9TB00860H crossref_primary_10_1186_s12987_023_00466_9 crossref_primary_10_1016_j_tibtech_2018_01_006 crossref_primary_10_3390_ijms241612541 crossref_primary_10_14336_AD_2022_0130_1 crossref_primary_10_3390_pharmaceutics13122045 crossref_primary_10_1126_sciadv_abc4397 crossref_primary_10_1186_s12987_020_00209_0 crossref_primary_10_1002_anie_201914751 crossref_primary_10_1515_ntrev_2022_0548 crossref_primary_10_3233_JAD_230098 crossref_primary_10_1002_adma_202301099 crossref_primary_10_1212_WNL_90_15_supplement_S5_008 crossref_primary_10_1038_s41551_021_00803_z crossref_primary_10_1007_s11095_022_03385_w crossref_primary_10_3390_cancers12102837 crossref_primary_10_1016_j_carbpol_2024_123207 crossref_primary_10_1016_j_addr_2022_114619 crossref_primary_10_3390_pharmaceutics12060579 crossref_primary_10_3389_fddev_2024_1360302 crossref_primary_10_1016_j_jconrel_2023_12_001 crossref_primary_10_32604_or_2024_047278 crossref_primary_10_1039_D1CS00574J crossref_primary_10_1002_adtp_202200001 crossref_primary_10_1016_j_mtadv_2023_100341 crossref_primary_10_1002_advs_202101090 crossref_primary_10_3390_pharmaceutics14061283 crossref_primary_10_1002_mabi_202000049 crossref_primary_10_2745_dds_33_377 crossref_primary_10_1002_smll_202300403 crossref_primary_10_3390_pharmaceutics13122024 crossref_primary_10_1186_s12951_023_01772_y crossref_primary_10_1002_adfm_201910369 crossref_primary_10_1016_j_jddst_2023_105267 crossref_primary_10_1016_j_mtbio_2021_100167 crossref_primary_10_1002_advs_202103148 crossref_primary_10_1002_advs_202004929 crossref_primary_10_1021_acscentsci_9b00843 crossref_primary_10_1021_acs_nanolett_4c03672 crossref_primary_10_1016_j_biomaterials_2019_119491 crossref_primary_10_3389_fnins_2022_939855 crossref_primary_10_1002_adhm_202100801 crossref_primary_10_1021_acsnano_1c08689 crossref_primary_10_4155_tde_2022_0035 crossref_primary_10_1002_asia_201701542 crossref_primary_10_1002_wnan_1898 crossref_primary_10_1016_j_mattod_2020_02_001 crossref_primary_10_1038_s41467_019_12554_2 crossref_primary_10_1038_s41573_021_00139_y crossref_primary_10_26508_lsa_202101193 crossref_primary_10_1016_j_jconrel_2022_04_013 crossref_primary_10_3390_cancers16193300 crossref_primary_10_1016_j_ejcb_2024_151406 crossref_primary_10_1080_17425247_2019_1583205 crossref_primary_10_1038_s44222_023_00138_1 crossref_primary_10_1021_acs_molpharmaceut_1c00297 crossref_primary_10_1016_j_bcp_2018_07_008 crossref_primary_10_1016_j_addr_2021_114029 crossref_primary_10_1021_acs_biomac_4c01052 crossref_primary_10_1021_jacs_0c09029 crossref_primary_10_1039_D1BM01506K crossref_primary_10_1016_j_apsb_2020_11_023 crossref_primary_10_1021_acs_chemrev_3c00705 crossref_primary_10_1021_acs_accounts_3c00151 crossref_primary_10_1021_acs_molpharmaceut_1c00856 crossref_primary_10_1016_j_biomaterials_2025_123138 crossref_primary_10_3390_biomedicines12092135 crossref_primary_10_1002_adtp_202300161 crossref_primary_10_1016_j_omtn_2023_102065 crossref_primary_10_1016_j_addr_2021_02_007 crossref_primary_10_1016_j_actbio_2025_01_016 crossref_primary_10_3390_pharmaceutics12121216 crossref_primary_10_3390_molecules28031151 crossref_primary_10_3390_nano12122072 crossref_primary_10_3389_fbioe_2023_1177151 crossref_primary_10_1002_jgm_3091 crossref_primary_10_1016_j_jconrel_2025_113595 crossref_primary_10_3390_ijms23020760 crossref_primary_10_1021_acs_molpharmaceut_7b01084 crossref_primary_10_1002_adfm_202200016 crossref_primary_10_1186_s12951_024_02940_4 crossref_primary_10_1080_17425247_2022_2139369 crossref_primary_10_1016_j_ajps_2020_07_001 crossref_primary_10_1002_ange_201914751 crossref_primary_10_1016_j_neurobiolaging_2018_05_010 crossref_primary_10_1016_j_biopha_2023_115174 crossref_primary_10_1016_j_copbio_2024_103108 crossref_primary_10_1016_j_addr_2021_113999 crossref_primary_10_1021_jacs_3c05638 crossref_primary_10_1016_j_fmre_2022_03_003 crossref_primary_10_3389_fonc_2024_1441460 crossref_primary_10_1016_j_jconrel_2018_04_034 crossref_primary_10_1021_acs_jafc_4c08452 crossref_primary_10_3390_pharmaceutics14061240 crossref_primary_10_1021_jacs_2c04418 crossref_primary_10_1038_s41598_018_22577_2 crossref_primary_10_1186_s40580_018_0168_8 crossref_primary_10_1039_C9BM01750J crossref_primary_10_1016_j_actbio_2021_12_003 crossref_primary_10_1021_jacs_4c02463 crossref_primary_10_1016_j_ccr_2022_214785 crossref_primary_10_1021_acs_langmuir_1c02390 crossref_primary_10_3390_ijms23084153 crossref_primary_10_1007_s13346_021_01008_2 crossref_primary_10_1016_j_ejmech_2025_117357 crossref_primary_10_1016_j_biomaterials_2024_122537 crossref_primary_10_1016_j_omtn_2024_102340 crossref_primary_10_1021_acsami_4c15671 crossref_primary_10_3389_fphar_2024_1333006 crossref_primary_10_1021_acsnano_9b09991 crossref_primary_10_1021_jacs_3c12502 crossref_primary_10_1016_j_ijpharm_2023_122924 crossref_primary_10_1021_acs_chemrev_8b00199 crossref_primary_10_1039_D2BM01572B crossref_primary_10_1039_D3NR06154J crossref_primary_10_1002_ctd2_43 crossref_primary_10_1016_j_biopha_2021_111354 crossref_primary_10_1016_j_jconrel_2019_01_006 crossref_primary_10_1016_j_jconrel_2020_09_043 crossref_primary_10_2217_nnm_2020_0088 crossref_primary_10_1002_adhm_202302902 crossref_primary_10_1016_j_mtnano_2023_100347 crossref_primary_10_3389_fncel_2022_1020644 crossref_primary_10_1016_j_jconrel_2024_05_044 crossref_primary_10_1126_sciadv_abd6889 crossref_primary_10_1016_j_phyplu_2024_100704 crossref_primary_10_3390_pharmaceutics14020361 crossref_primary_10_1016_j_nantod_2021_101239 crossref_primary_10_1016_j_ijbiomac_2025_139532 crossref_primary_10_1126_sciadv_abc7031 crossref_primary_10_1016_j_jconrel_2024_12_066 crossref_primary_10_1016_j_mtbio_2020_100055 crossref_primary_10_1016_j_pharmthera_2023_108527 crossref_primary_10_1002_adma_201902604 crossref_primary_10_1016_j_biomaterials_2019_119752 crossref_primary_10_1073_pnas_1912012117 crossref_primary_10_2217_nnm_2021_0486 crossref_primary_10_1016_j_bmc_2020_115852 crossref_primary_10_1016_j_jcis_2024_05_067 crossref_primary_10_1002_advs_202105854 crossref_primary_10_1016_j_jconrel_2019_02_021 crossref_primary_10_1016_j_jconrel_2020_10_043 crossref_primary_10_1021_acs_macromol_2c00557 crossref_primary_10_1021_acs_biomac_4c00210 crossref_primary_10_3390_pharmaceutics13081193 crossref_primary_10_1016_j_apsb_2022_05_016 crossref_primary_10_1021_acs_biomac_9b01291 crossref_primary_10_1039_D1NA00145K crossref_primary_10_1021_acsbiomaterials_1c00730 crossref_primary_10_1002_cnma_202200014 crossref_primary_10_1002_adma_202208018 crossref_primary_10_1038_s41598_020_75253_9 crossref_primary_10_1007_s11095_022_03223_z crossref_primary_10_1016_j_nantod_2022_101556 crossref_primary_10_1021_acsnano_1c00316 crossref_primary_10_3389_fphar_2021_756724 |
Cites_doi | 10.1038/nmat1081 10.2147/IJN.S23771 10.1111/apha.12250 10.1042/bj1310211 10.1364/BOE.1.001209 10.1038/nrd1088 10.1111/j.1600-0854.2009.00894.x 10.1038/nnano.2011.166 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3 10.1038/nrm2755 10.1111/j.1528-1167.2012.03637.x 10.1016/j.nbd.2009.07.030 10.1021/bi2000356 10.1016/j.biomaterials.2013.09.094 10.1056/NEJMra0912273 10.1529/biophysj.104.047886 10.1073/pnas.1000346107 10.1046/j.1471-4159.1999.0720238.x 10.1016/j.jconrel.2014.06.042 10.1038/nrd2591 10.1038/nrd.2015.21 10.1038/nrm3351 10.1038/nrc1566 10.1038/bjc.2011.6 10.1111/j.1471-4159.2011.07208.x 10.1203/PDR.0b013e31815b440b 10.1038/sj.bjc.6603855 10.1073/pnas.1307152110 10.3109/10611861003587235 10.1038/nrd4363 10.1161/01.STR.14.3.388 10.1038/nnano.2007.70 10.1002/jnr.490220413 10.1016/j.jconrel.2009.03.002 10.1016/S0021-9258(19)85527-8 |
ContentType | Journal Article |
Copyright | The Author(s) 2017 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2017 – notice: 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 SOI 7X8 5PM DOA |
DOI | 10.1038/s41467-017-00952-3 |
DatabaseName | Springer Nature Link OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts ProQuest - Health & Medical Complete保健、医学与药学数据库 ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Medical Database Biological Science Database ProQuest advanced technologies & aerospace journals ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts Environment Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2041-1723 |
EndPage | 9 |
ExternalDocumentID | oai_doaj_org_article_0fc143dfc7464c2e803e239b8d4ccb42 PMC5645389 29042554 10_1038_s41467_017_00952_3 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 0R~ 39C 3V. 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ACSMW ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BAPOH BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LK8 M1P M48 M7P M~E NAO O9- OK1 P2P P62 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AARCD AZQEC C1K DWQXO FR3 GNUQQ H94 K9. P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 SOI 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c584t-55eb5f6416d3f69edf908cc4324419e43a4799fa8b567cd0d4c19449b4372a013 |
IEDL.DBID | 8FG |
ISSN | 2041-1723 |
IngestDate | Wed Aug 27 01:08:53 EDT 2025 Thu Aug 21 13:52:07 EDT 2025 Fri Sep 05 10:46:52 EDT 2025 Wed Aug 13 11:00:59 EDT 2025 Wed Feb 19 02:36:06 EST 2025 Thu Apr 24 22:50:28 EDT 2025 Tue Jul 01 02:21:05 EDT 2025 Fri Feb 21 02:39:47 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c584t-55eb5f6416d3f69edf908cc4324419e43a4799fa8b567cd0d4c19449b4372a013 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-0530-1326 |
OpenAccessLink | https://www.proquest.com/docview/1952162794?pq-origsite=%requestingapplication% |
PMID | 29042554 |
PQID | 1952162794 |
PQPubID | 546298 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_0fc143dfc7464c2e803e239b8d4ccb42 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5645389 proquest_miscellaneous_1952529624 proquest_journals_1952162794 pubmed_primary_29042554 crossref_primary_10_1038_s41467_017_00952_3 crossref_citationtrail_10_1038_s41467_017_00952_3 springer_journals_10_1038_s41467_017_00952_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-10-17 |
PublicationDateYYYYMMDD | 2017-10-17 |
PublicationDate_xml | – month: 10 year: 2017 text: 2017-10-17 day: 17 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Nature communications |
PublicationTitleAbbrev | Nat Commun |
PublicationTitleAlternate | Nat Commun |
PublicationYear | 2017 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
References | Gerhart, LeVasseur, Broderius, Drewes (CR30) 1989; 22 Mammen, Choi, Whitesides (CR24) 1998; 37 Matsumoto (CR28) 2010; 1 Xie (CR20) 2012; 7 Petros, DeSimone (CR5) 2010; 9 Nishiyama (CR9) 2003; 63 Marchi, Granata, Ghosh, Janigro (CR36) 2012; 53 Mitragotri, Burke, Langer (CR4) 2014; 13 Cabral, Kataoka (CR14) 2014; 190 Yoo, Mitragotri (CR2) 2010; 107 Cabral (CR1) 2011; 6 Riskin, Nannegari, Mond (CR32) 2008; 63 Plummer (CR12) 2011; 104 Qin (CR21) 2010; 18 Jiang (CR37) 2014; 35 Grant, Donaldson (CR33) 2009; 10 Duncan (CR10) 2003; 2 Underhill, Toole (CR23) 1980; 255 Simpson (CR27) 1999; 72 Hamaguchi (CR13) 2007; 97 Ferrari (CR7) 2005; 5 Alexis, Pavel, Felipe, Juan, Jorge (CR25) 2004; 87 Leto, Saltiel (CR34) 2012; 13 Zensi (CR18) 2009; 137 Oldendorf, Crane, Lawner, Braun (CR38) 1983; 14 Napoli (CR6) 2004; 3 Foley, Boguslavsky, Klip (CR35) 2011; 50 Geng (CR3) 2007; 2 Matsumura, Maeda (CR8) 1986; 46 CR22 Wiley, Webster, Gale, Davis (CR17) 2013; 110 Abbott, Patabendige, Dolman, Yusof, Begley (CR15) 2010; 37 Banks (CR16) 2016; 15 Uchida (CR19) 2011; 117 Muoio, Persson, Sendeski (CR29) 2014; 210 Barnett, Holman, Munday (CR26) 1973; 131 Eyster (CR31) 2009; 10 Kim, Rutka, Chan (CR11) 2010; 363 SB Alexis (952_CR25) 2004; 87 952_CR22 Y Geng (952_CR3) 2007; 2 Y Uchida (952_CR19) 2011; 117 D Leto (952_CR34) 2012; 13 CA Eyster (952_CR31) 2009; 10 A Zensi (952_CR18) 2009; 137 DZ Gerhart (952_CR30) 1989; 22 Y Matsumoto (952_CR28) 2010; 1 RA Petros (952_CR5) 2010; 9 R Plummer (952_CR12) 2011; 104 IA Simpson (952_CR27) 1999; 72 S Mitragotri (952_CR4) 2014; 13 N Nishiyama (952_CR9) 2003; 63 R Duncan (952_CR10) 2003; 2 N Marchi (952_CR36) 2012; 53 T Hamaguchi (952_CR13) 2007; 97 JW Yoo (952_CR2) 2010; 107 NJ Abbott (952_CR15) 2010; 37 WA Banks (952_CR16) 2016; 15 BY Kim (952_CR11) 2010; 363 M Mammen (952_CR24) 1998; 37 F Xie (952_CR20) 2012; 7 A Napoli (952_CR6) 2004; 3 CB Underhill (952_CR23) 1980; 255 WH Oldendorf (952_CR38) 1983; 14 JEG Barnett (952_CR26) 1973; 131 M Ferrari (952_CR7) 2005; 5 H Cabral (952_CR1) 2011; 6 K Foley (952_CR35) 2011; 50 V Muoio (952_CR29) 2014; 210 Y Matsumura (952_CR8) 1986; 46 Y Qin (952_CR21) 2010; 18 DT Wiley (952_CR17) 2013; 110 X Jiang (952_CR37) 2014; 35 H Cabral (952_CR14) 2014; 190 BD Grant (952_CR33) 2009; 10 A Riskin (952_CR32) 2008; 63 |
References_xml | – volume: 3 start-page: 183 year: 2004 end-page: 189 ident: CR6 article-title: Oxidation-responsive polymeric vesicles publication-title: Nat. Mater. doi: 10.1038/nmat1081 – ident: CR22 – volume: 7 start-page: 163 year: 2012 end-page: 175 ident: CR20 article-title: Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S23771 – volume: 210 start-page: 790 year: 2014 end-page: 798 ident: CR29 article-title: The neurovascular unit – concept review publication-title: Acta Physiol. doi: 10.1111/apha.12250 – volume: 131 start-page: 211 year: 1973 end-page: 221 ident: CR26 article-title: Structural requirements for binding to the sugar-transport system of the human erythrocyte publication-title: Biochem. J. doi: 10.1042/bj1310211 – volume: 1 start-page: 1209 year: 2010 end-page: 1216 ident: CR28 article-title: Direct and instantaneous observation of intravenously injected substances using intravital confocal micro-videography publication-title: Biomed. Opt. Express doi: 10.1364/BOE.1.001209 – volume: 2 start-page: 347 year: 2003 end-page: 360 ident: CR10 article-title: The dawning era of polymer therapeutics publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd1088 – volume: 10 start-page: 590 year: 2009 end-page: 599 ident: CR31 article-title: Discovery of new cargo proteins that enter cells through clathrin-independent endocytosis publication-title: Traffic doi: 10.1111/j.1600-0854.2009.00894.x – volume: 6 start-page: 815 year: 2011 end-page: 823 ident: CR1 article-title: Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size publication-title: Nat. Nanotechnol doi: 10.1038/nnano.2011.166 – volume: 46 start-page: 6387 year: 1986 end-page: 6392 ident: CR8 article-title: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs publication-title: Cancer Res. – volume: 37 start-page: 2754 year: 1998 end-page: 2794 ident: CR24 article-title: Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors publication-title: Angew. Chem. Int. Ed. doi: 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3 – volume: 10 start-page: 597 year: 2009 end-page: 608 ident: CR33 article-title: Pathways and mechanisms of endocytic recycling publication-title: Nat. Rev. Mol. Cell. Biol. doi: 10.1038/nrm2755 – volume: 53 start-page: 1877 year: 2012 end-page: 1886 ident: CR36 article-title: Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches publication-title: Epilepsia doi: 10.1111/j.1528-1167.2012.03637.x – volume: 37 start-page: 13 year: 2010 end-page: 25 ident: CR15 article-title: Structure and function of the blood–brain barrier publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2009.07.030 – volume: 50 start-page: 3048 year: 2011 end-page: 3061 ident: CR35 article-title: Endocytosis, recycling, and regulated exocytosis of glucose transporter 4 publication-title: Biochemistry doi: 10.1021/bi2000356 – volume: 35 start-page: 518 year: 2014 end-page: 529 ident: CR37 article-title: Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment publication-title: Biomaterials doi: 10.1016/j.biomaterials.2013.09.094 – volume: 363 start-page: 2434 year: 2010 end-page: 2443 ident: CR11 article-title: Nanomedicine publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra0912273 – volume: 87 start-page: 2990 year: 2004 end-page: 2999 ident: CR25 article-title: Predicting the three-dimensional structure of the human facilitative glucose transporter glut1 by a novel evolutionary homology strategy: Insights on the molecular mechanism of substrate migration, and binding sites for glucose and inhibitory molecules publication-title: Biophys. J. doi: 10.1529/biophysj.104.047886 – volume: 107 start-page: 11205 year: 2010 end-page: 11210 ident: CR2 article-title: Polymer particles that switch shape in response to a stimulus publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1000346107 – volume: 63 start-page: 8977 year: 2003 end-page: 8983 ident: CR9 article-title: Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice publication-title: Cancer Res. – volume: 72 start-page: 238 year: 1999 end-page: 247 ident: CR27 article-title: Blood–brain barrier glucose transporter: Effects of hypo- and hyperglycemia revisited publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1999.0720238.x – volume: 190 start-page: 465 year: 2014 end-page: 476 ident: CR14 article-title: Progress of drug-loaded polymeric micelles into clinical studies publication-title: J. Control. Release doi: 10.1016/j.jconrel.2014.06.042 – volume: 9 start-page: 615 year: 2010 end-page: 627 ident: CR5 article-title: Strategies in the design of nanoparticles for therapeutic applications publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd2591 – volume: 15 start-page: 275 year: 2016 end-page: 292 ident: CR16 article-title: From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery publication-title: Nat. Rev. Drug. Discov. doi: 10.1038/nrd.2015.21 – volume: 13 start-page: 383 year: 2012 end-page: 396 ident: CR34 article-title: Regulation of glucose transport by insulin: traffic control of GLUT4 publication-title: Nat. Rev. Mol. Cell. Biol. doi: 10.1038/nrm3351 – volume: 5 start-page: 161 year: 2005 end-page: 171 ident: CR7 article-title: Cancer nanotechnology: opportunities and challenges publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1566 – volume: 104 start-page: 593 year: 2011 end-page: 598 ident: CR12 article-title: A phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours publication-title: Br. J. Cancer doi: 10.1038/bjc.2011.6 – volume: 117 start-page: 333 year: 2011 end-page: 345 ident: CR19 article-title: Quantitative targeted absolute proteomics of human blood–brain barrier transporters and receptors publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.2011.07208.x – volume: 63 start-page: 56 year: 2008 end-page: 61 ident: CR32 article-title: Acute effectors of GLUT1 glucose transporter subcellular targeting in CIT mouse mammary epithelial cells publication-title: Pediatr. Res. doi: 10.1203/PDR.0b013e31815b440b – volume: 97 start-page: 170 year: 2007 end-page: 176 ident: CR13 article-title: A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6603855 – volume: 110 start-page: 8662 year: 2013 end-page: 8667 ident: CR17 article-title: Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1307152110 – volume: 18 start-page: 536 year: 2010 end-page: 549 ident: CR21 article-title: and investigation of glucose-mediated brain-targeting liposomes publication-title: J. Drug Target. doi: 10.3109/10611861003587235 – volume: 13 start-page: 655 year: 2014 end-page: 672 ident: CR4 article-title: Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4363 – volume: 14 start-page: 388 year: 1983 end-page: 393 ident: CR38 article-title: Rapid, transient drop in brain glucose after intravenous phloretin or 3-O-methyl-D-glucose publication-title: Stroke doi: 10.1161/01.STR.14.3.388 – volume: 2 start-page: 249 year: 2007 end-page: 255 ident: CR3 article-title: Shape effects of filaments versus spherical particles in flow and drug delivery publication-title: Nat. Nanotechnol doi: 10.1038/nnano.2007.70 – volume: 22 start-page: 464 year: 1989 end-page: 472 ident: CR30 article-title: Glucose transporter localization in brain using light and electron immunocytochemistry publication-title: J. Neurosci. Res. doi: 10.1002/jnr.490220413 – volume: 137 start-page: 78 year: 2009 end-page: 86 ident: CR18 article-title: Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones publication-title: J. Control. Release doi: 10.1016/j.jconrel.2009.03.002 – volume: 255 start-page: 4544 year: 1980 end-page: 4549 ident: CR23 article-title: Physical characteristics of hyaluronate binding to the surface of simian virus 40-transformed 3T3 cells publication-title: J. Biol. Chem. – volume: 18 start-page: 536 year: 2010 ident: 952_CR21 publication-title: J. Drug Target. doi: 10.3109/10611861003587235 – volume: 37 start-page: 2754 year: 1998 ident: 952_CR24 publication-title: Angew. Chem. Int. Ed. doi: 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3 – volume: 131 start-page: 211 year: 1973 ident: 952_CR26 publication-title: Biochem. J. doi: 10.1042/bj1310211 – volume: 72 start-page: 238 year: 1999 ident: 952_CR27 publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1999.0720238.x – volume: 10 start-page: 597 year: 2009 ident: 952_CR33 publication-title: Nat. Rev. Mol. Cell. Biol. doi: 10.1038/nrm2755 – volume: 104 start-page: 593 year: 2011 ident: 952_CR12 publication-title: Br. J. Cancer doi: 10.1038/bjc.2011.6 – volume: 2 start-page: 347 year: 2003 ident: 952_CR10 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd1088 – volume: 2 start-page: 249 year: 2007 ident: 952_CR3 publication-title: Nat. Nanotechnol doi: 10.1038/nnano.2007.70 – volume: 97 start-page: 170 year: 2007 ident: 952_CR13 publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6603855 – volume: 255 start-page: 4544 year: 1980 ident: 952_CR23 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)85527-8 – volume: 190 start-page: 465 year: 2014 ident: 952_CR14 publication-title: J. Control. Release doi: 10.1016/j.jconrel.2014.06.042 – volume: 137 start-page: 78 year: 2009 ident: 952_CR18 publication-title: J. Control. Release doi: 10.1016/j.jconrel.2009.03.002 – volume: 5 start-page: 161 year: 2005 ident: 952_CR7 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1566 – volume: 53 start-page: 1877 year: 2012 ident: 952_CR36 publication-title: Epilepsia doi: 10.1111/j.1528-1167.2012.03637.x – volume: 13 start-page: 383 year: 2012 ident: 952_CR34 publication-title: Nat. Rev. Mol. Cell. Biol. doi: 10.1038/nrm3351 – volume: 87 start-page: 2990 year: 2004 ident: 952_CR25 publication-title: Biophys. J. doi: 10.1529/biophysj.104.047886 – volume: 9 start-page: 615 year: 2010 ident: 952_CR5 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd2591 – volume: 63 start-page: 56 year: 2008 ident: 952_CR32 publication-title: Pediatr. Res. doi: 10.1203/PDR.0b013e31815b440b – volume: 37 start-page: 13 year: 2010 ident: 952_CR15 publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2009.07.030 – volume: 10 start-page: 590 year: 2009 ident: 952_CR31 publication-title: Traffic doi: 10.1111/j.1600-0854.2009.00894.x – volume: 7 start-page: 163 year: 2012 ident: 952_CR20 publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S23771 – volume: 1 start-page: 1209 year: 2010 ident: 952_CR28 publication-title: Biomed. Opt. Express doi: 10.1364/BOE.1.001209 – volume: 22 start-page: 464 year: 1989 ident: 952_CR30 publication-title: J. Neurosci. Res. doi: 10.1002/jnr.490220413 – volume: 15 start-page: 275 year: 2016 ident: 952_CR16 publication-title: Nat. Rev. Drug. Discov. doi: 10.1038/nrd.2015.21 – volume: 210 start-page: 790 year: 2014 ident: 952_CR29 publication-title: Acta Physiol. doi: 10.1111/apha.12250 – ident: 952_CR22 – volume: 363 start-page: 2434 year: 2010 ident: 952_CR11 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra0912273 – volume: 117 start-page: 333 year: 2011 ident: 952_CR19 publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.2011.07208.x – volume: 35 start-page: 518 year: 2014 ident: 952_CR37 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2013.09.094 – volume: 6 start-page: 815 year: 2011 ident: 952_CR1 publication-title: Nat. Nanotechnol doi: 10.1038/nnano.2011.166 – volume: 63 start-page: 8977 year: 2003 ident: 952_CR9 publication-title: Cancer Res. – volume: 14 start-page: 388 year: 1983 ident: 952_CR38 publication-title: Stroke doi: 10.1161/01.STR.14.3.388 – volume: 3 start-page: 183 year: 2004 ident: 952_CR6 publication-title: Nat. Mater. doi: 10.1038/nmat1081 – volume: 50 start-page: 3048 year: 2011 ident: 952_CR35 publication-title: Biochemistry doi: 10.1021/bi2000356 – volume: 13 start-page: 655 year: 2014 ident: 952_CR4 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4363 – volume: 46 start-page: 6387 year: 1986 ident: 952_CR8 publication-title: Cancer Res. – volume: 107 start-page: 11205 year: 2010 ident: 952_CR2 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1000346107 – volume: 110 start-page: 8662 year: 2013 ident: 952_CR17 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1307152110 |
SSID | ssj0000391844 |
Score | 2.625088 |
Snippet | Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression... There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1001 |
SubjectTerms | 631/378/1341 631/61/350/2093 639/925/352/152 Accumulation Animals Biological activity Blood Glucose - metabolism Blood-brain barrier Blood-Brain Barrier - metabolism Brain - blood supply Brain - metabolism Cell migration Drug Carriers - metabolism Drug Carriers - pharmacokinetics Endothelial cells Female Glucose Glucose - metabolism Glucose transporter Glucose Transporter Type 1 - metabolism Glycosylation Humanities and Social Sciences Humans Mice, Inbred BALB C Micelles Microscopy, Confocal multidisciplinary Nanoparticles - metabolism Neurons Neurons - metabolism Polymers - chemistry Polymers - metabolism Science Science (multidisciplinary) Transport |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxsxEBYhUMil9JG226ZFgdzaJdJK2pWOdWkaCgkEGshNaPWgAbMO8ebgf98ZaW3sPi892tLaw7fz-MSMZgg5YZ1zwPL7Wim8kqO6WGuvVa2dTCG1EHA53h2-uGzPr-XXG3WzNeoLa8JKe-AC3ClLHkJ6SL6TrfRN1EzERpheB-l9L7P3ZYZtHaayDxYGji5yuiXDhD5dyuwT0CkjrWhqsROJcsP-37HMX4slf8qY5kB09oQ8nhgk_Vgkf0r24vCMPCozJVfPydWX-co7LHmnUxk6BSK9HJe0VKev5sAuAx3cAFHsHufV0Swf_BcFMkhnsxm9HcZF_tDjAIlDcn32-dun83qam1B7oBMjwB57lVqgWkGk1sSQDNPeY-89yU2UwsnOmOR0r9rOBwZIciOl6TGH54ATviD7w2KIrwgFi4-MpwSnQCalcppLOGCYNonQpKB4RfgaQ-unpuI422Juc3JbaFtwt4C7zbhbUZH3m2fuSkuNv-6e4avZ7MR22PkLUBI7KYn9l5JU5Gj9Yu1ko0vL4fd524BDqsjxZhmsC1MmboiLh7IHM9MN7HlZ9GAjSWPQ4SlY6XY0ZEfU3ZXh9nvu4I0tfIApVuTDWpe2xPojFK__BxRvyEGDRoBFOd0R2R_vH-Jb4FVj_y6b0A_QWRv3 priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA_nieCL-G31lAi-abX5bPIg4ornIZwguHBvIU2T82Dp6m4P3P_embRdXF3vsU3appP5-A0zmSHkRVV7Dyi_KZXCIzmqjqUJRpXGy9QmDQaX4dnh0y_6ZC4_n6mzAzK1OxoJuN7r2mE_qflq8frXz807EPi3w5Fx82Yts7ijvkXEwEtxjVwHy6TRGTsd4X7WzMKCQyPHszP7H92xT7mM_z7s-W8K5V9x1Gyejm-TWyOupO8HRrhDDmJ3l9wYOk1u7pGvnxab4DERno7J6RTg9bpf0yFnfbMAzNnSzndg21bYxY7m9cG3KEBEOpvN6EXXL_NFg20l7pP58cdvH07KsZtCGQBk9LAZsVFJA1lakbSNbbKVCQEr8klmoxRe1tYmbxql69BWrQzMSmkbjOx5QIoPyGG37OIjQkEPxIqlBL5hJaXyhklwO6xOouWpVawgbKKhC2Opcex4sXA55C2MG-jugO4u092JgrzcPvNjKLRx5ewZbs12JhbJzjeWq3M3ypyrUgA02KZQSy0Dj6YSkQvbGPi10EhekKNpY93EeI7B-5nmoKYK8nw7DDKHgRTfxeXlMAfj1RzmPBz4YLsSblENKhipdzhkZ6m7I93F91zXGwv7AH4syKuJl_5Y1n9J8fjqv3hCbnJkb0zCqY_IYb-6jE8BR_XNsywcvwEjwBZB priority: 102 providerName: Scholars Portal – databaseName: Springer Nature Link OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEA-1Ivgi1s_VViL4pou7-drk0Ttai6AgWOhbyOZDC8ee3G0f7r93JvuBp1Xo421m9-ZmZ5Jfbia_IeRN1TgHKL8tpcQjObKJpfZaltqJFJKCBbfGs8Ofv6jzC_HpUl4eEDadhclF-5nSMk_TU3XY-63IIY1zKqICVvI75K6GfR169VIt5_9VkPFcCzGej6m4vuHWvTUoU_XfhC__LpP8I1eal6Czh-TBiB3ph0HbI3IQu0fk3tBNcveYfP242nmHxe50LECnAKG3_ZYOdem7FeDKQDvXwfq1wU51NOsH30UBBtLFYkGvun6dP7TYOuIJuTg7_bY8L8eOCaUHINGDwWMrkwKQFXhSJoZkKu09su6J2kTBnWiMSU63UjU-VEH42ghhWszeOUCDT8lht-7ic0Ih1mNVpwT7v0oI6XQtYGthVOKBpSDrgtSTDa0f6cSxq8XK5rQ213awuwW722x3ywvydr7n50Cm8V_pBb6aWRKJsPOF9ea7HR3DVskD4gvJN0IJz6KueGTctBp-mm8FK8jx9GLtGJ1bW8Pza8VgKirI63kY4gqTJa6L6-tBBnPSDGSeDX4wa8IMTnUSRpo9D9lTdX-ku_qRubuRvAcwYkHeTb70m1r_NMWL24m_JPcZujsW3jTH5LDfXMcTwE59-yoHyy-cBhDR priority: 102 providerName: Springer Nature |
Title | Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain |
URI | https://link.springer.com/article/10.1038/s41467-017-00952-3 https://www.ncbi.nlm.nih.gov/pubmed/29042554 https://www.proquest.com/docview/1952162794 https://www.proquest.com/docview/1952529624 https://pubmed.ncbi.nlm.nih.gov/PMC5645389 https://doaj.org/article/0fc143dfc7464c2e803e239b8d4ccb42 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb5wwELaaRJV6qfouabpypd5aFB422KdqWWUTrZSor0h7Q8bYaaQVpAs57L_PjPHSbh-5gMBGmPE8PjzjGULeR7lSgPKrkHPcksNzEwoteCgUs7XNwODGuHf4_CI7u2SLJV_6BbfOh1VudaJT1HWrcY38OJZgaLIE2OfTzc8Qq0ahd9WX0NgjBzFYGuRzMT8d11gw-7lgzO-ViVJx3DGnGVA1I7hIwnTHHrm0_f_Cmn-HTP7hN3XmaP6EPPY4kk6HiX9KHpjmGXk4VJbcPCdfTlcbrTDwnfpgdApwuus7OsSob1aAMWvaqAZs2Rqr1lE3PngXBUhIi6Kg103fuosKy0i8IJfzk--zs9BXTwg1gIoeiG8qbjMAXHVqM2lqKyOhNWbgY7E0LFUsl9IqUfEs13VUMx1LxmSFnjwFyPAl2W_axrwmFOTeRLG18C8YMcaViBn8ZsjMpnViax4HJN7SsNQ-tThWuFiVzsWdinKgewl0Lx3dyzQgH8ZnbobEGvf2LnBqxp6YFNvdaNdXpZexMrIa0F9tdc4yphMjotQkqawEfJquWBKQo-3Ell5Su_IXXwXk3dgMMoaOE9WY9nbog_7pBPq8GvhgHEkiUe1xaMl3OGRnqLstzfUPl8cbE_kAXgzIxy0v_Tas_5Li8P6veEMeJcjeGHSTH5H9fn1r3gJu6qsJ2cuX-cSJyIQcTKeLbws4FycXn7_C3Vk2m7gVCTieM3EH8e4Zyg |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELZKEYIXxE2ggJHgCaImjpPYDwixQNnSQ0JqpX0zjg-otMqWTSq0f4rfyIxzwHL0rY-7dnYn4zk-e8YzhDxLSq0B5VdxnuOVnLx0sTAij4Xm3voCHG6Kd4cPDovpMf84y2cb5MdwFwbTKgebGAy1XRg8I99OJTiagoH4vD79FmPXKIyuDi00OrHYc6vvsGVrXu2-g_V9ztjO-6O307jvKhAbcLYtEOWq3BcARGzmC-msl4kwBivT8VQ6nmleSum1qPKiNDax3MBGn8sKI1waEBP87iVymePJOOhPOSvHMx2sti447-_mJJnYbniwROgKEMywOFvzf6FNwL-w7d8pmn_EaYP727lBrve4lb7pBO0m2XD1LXKl62S5uk0-fZivjMZEe9onv1OA703b0C4nfjUHTGtprWvwnUvskkcDffBfFCAonUwm9KRuF-FDhW0r7pDjC-HrXbJZL2p3n1CwMy5JvYe9Z8J5rkXKYVsjC59Z5m2eRiQdeKhMX8ocO2rMVQipZ0J1fFfAdxX4rrKIvBifOe0KeZw7e4JLM87EItzhi8Xyi-p1WiXeANq03pS84IY5kWSOZbIS8Gqm4iwiW8PCqt4yNOqXHEfk6TgMOo2BGl27xVk3B-PhDObc6-RgpIRJNLM5jJRrErJG6vpIffI11A3HwkGATyPycpCl38j6LysenP8WT8jV6dHBvtrfPdx7SK4xFHVM-Cm3yGa7PHOPALO11eOgKJR8vmjN_AnUvE7C |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYgL4k2ggJHgBNEmtpPYB4RYyralUIFEpd5M4gdUWiVlkwrtX-PXMeMkC8ujtx43drKT8Xjmm8x4hpAnSVGWgPKrOMvwSE5WuFgamcWyFN76HAxuimeH3x_ku4fi7VF2tEF-jGdhMK1y1IlBUdvG4DfySarA0OQMxGfih7SID9uzlyffYuwghZHWsZ1GLyL7bvkd3Lf2xd42rPVTxmZvPr3ejYcOA7EBw9sBga7KfA6gxHKfK2e9SqQxWKVOpMoJXopCKV_KKssLYxMrDDj9QlUY7SoBPcFzL5CLBS8UOn5ytrP6voOV16UQwzmdhMtJK4JWQrOAwIbFfM0WhpYB_8K5f6dr_hGzDaZwdo1cHTAsfdUL3XWy4eob5FLf1XJ5k3zcmS9NiUn3dEiEpwDl266lfX78cg741tK6rMGOLrBjHg30wX9RgKN0Op3S47prwo8KW1jcIofnwtfbZLNuaneXUNA5Lkm9Bz80ESIrZSrAxVG555Z5m6URSUceajOUNcfuGnMdwutc6p7vGviuA981j8iz1T0nfVGPM2dPcWlWM7Egd7jQLL7oYX_rxBtAntabQuTCMCcT7hhXlYRXM5VgEdkaF1YPWqLVv2Q6Io9Xw7C_MWhT1q457edgbJzBnDu9HKwoYQpVbgYjxZqErJG6PlIffw01xLGIEGDViDwfZek3sv7Lintnv8Ujchn2pH63d7B_n1xhKOmY-1Nskc1uceoeAHzrqodhn1Dy-bw35k_pslMK |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glycaemic+control+boosts+glucosylated+nanocarrier+crossing+the+BBB+into+the+brain&rft.jtitle=Nature+communications&rft.au=Anraku%2C+Y&rft.au=Kuwahara%2C+H&rft.au=Fukusato%2C+Y&rft.au=Mizoguchi%2C+A&rft.date=2017-10-17&rft.pub=Nature+Publishing+Group&rft.eissn=2041-1723&rft.volume=8&rft.spage=1&rft.epage=9&rft_id=info:doi/10.1038%2Fs41467-017-00952-3&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon |